Company / SG&A per Share
Vivos Therapeutics, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.04
FY2025
5-year range
$0.88 / $31.55
FY2021-FY2025
Trend
-75.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $31.55 to $3.04 over the past 2 years.
Based on SEC 10-K filings.
3.04 in FY2025 with a 5-year CAGR of +18.5%.
Improved from $31.55 to $3.04 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +39.4%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 75.2% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.04 | -75.2% |
| FY2024 | $12.26 | -61.1% |
| FY2023 | $31.55 | +2714.7% |
| FY2022 | $1.12 | +26.8% |
| FY2021 | $0.88 | -32.0% |
| FY2020 | $1.30 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026